1
2
Nov. 20, 2020 The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study, researchers provide further proof of this by showing that mumps IgG titers, or ...
July 27, 2022 New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger ...
Sep. 13, 2022 Current vaccination strategies are unlikely to eliminate measles, according to a new study. The paper explores the feasibility of eliminating measles and rubella using predominant vaccination ...
Dec. 17, 2020 Researchers evaluated changes in measles vaccination rates from before the pandemic to this summer, when return for clinical care was encouraged. Finding a steep and lasting decline, the researchers ...
Nov. 16, 2020 Major measles outbreaks will likely occur during 2021 as an unexpected consequence of the COVID-19 pandemic, according to a new academic ...
Aug. 31, 2021 Laboratory and retrospective analyses suggest that MMR and Tdap memory T cells are activated by SARS-CoV-2 and decrease COVID-19 ...
Jan. 11, 2023 Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the ...
Apr. 29, 2021 More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research ...
Jan. 21, 2021 Researchers have developed a new integrated genetic/epigenetic DNA-sequencing protocol known as MultiMMR that can identify the presence and cause of mismatch repair (MMR) deficiency in a single test ...
Feb. 3, 2021 An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study. The investigational vaccine, called Ad4-H5-VTN, is a ...